Felipe Gálvez-Cancino

8PUBLICATIONS
62CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 08, 2026
Engineering and Improving Anti-CTLA-4 Checkpoint Inhibitors.

|Mar 30, 2026
Lymphodepleting preconditioning impairs host antitumor immunity induced by adoptive T cell therapy in mouse models.

Diego Figueroa, Juan Pablo Vega, Andrés Hernández-Oliveras

|Dec 02, 2025
Facts and Hopes in Harnessing Macrophage-Mediated Antibody-Dependent Cellular Phagocytosis for Cancer Immunotherapy.

Maria Armero, Manuel Smolkin, Mario Garcia-Dominguez

|Sep 04, 2025
The Dark Side of NK Cells in Cancer Immunotherapy.

Felipe Galvez-Cancino, Maria Armero, David R Withers

|Feb 19, 2025
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.

Maise Al Bakir, James L Reading, Samuel Gamble

|Oct 02, 2024
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution.

Clare Puttick, Thomas P Jones, Michelle M Leung

Pageof 2

Frequent Collaborators

4 joint publications

Sergio A Quezada

3 joint publications

Charles Swanton

3 joint publications

Ignacio Melero

2 joint publications

Manuel Varas-Godoy